During the past decade, Poradnia Pulmonologiczna dla Doroslych conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Poradnia Pulmonologiczna dla Doroslych" are "Asthma" (1 trials) and "Chronic Obstructive Pulmonary Disease" (1 trials). Many other conditions were trialed in "Poradnia Pulmonologiczna dla Doroslych" in a lesser frequency.

Most popular intervention types in "Poradnia Pulmonologiczna dla Doroslych" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lebrikizumab" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Poradnia Pulmonologiczna dla Doroslych" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Poradnia Pulmonologiczna dla Doroslych". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Poradnia Pulmonologiczna dla Doroslych, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Poradnia Pulmonologiczna dla Doroslych, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".